Lanthanide nanohybrids show promise in treating pulmonary biofilm infections
Bacterial biofilm infections are among the leading causes of morbidity and mortality among patients with cystic fibrosis or those with weakened immune systems. Treatment for biofilm infections usually entails intensive antibiotic ...